Skip to main content
Author Correction: Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.
Extension of efficacy range for targeted malaria-elimination interventions due to spillover effects.
Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.
Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation.
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer.
Author Correction: Pan-viral serology implicates enteroviruses in acute flaccid myelitis.